These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 743009

  • 1. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
    Brunner H, Mann H, Essers U, Schultheis R, Byrne T, Heintz R.
    Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
    [Abstract] [Full Text] [Related]

  • 2. Combination of conventional and high-performance liquid chromatographic techniques for the isolation of so-called "uraemic toxins".
    Brunner H, Mann H.
    J Chromatogr; 1984 Aug 03; 297():405-16. PubMed ID: 6490772
    [Abstract] [Full Text] [Related]

  • 3. Large-scale isolation of middle and higher molecular weight uremic toxins.
    Brunner H, Mann H, Essers U, Byrne T.
    Artif Organs; 1981 Aug 03; 4 Suppl():41-5. PubMed ID: 7295094
    [Abstract] [Full Text] [Related]

  • 4. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G, Strecker G, Cueille G, Boudet J, Man NK, Galli A, Agneray J.
    Artif Organs; 1981 Aug 03; 4 Suppl():17-21. PubMed ID: 7295087
    [Abstract] [Full Text] [Related]

  • 5. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A, Myśliwiec M, Soszka J.
    Pol Tyg Lek; 1981 Aug 03; 45(40-41):810-3. PubMed ID: 2096374
    [Abstract] [Full Text] [Related]

  • 6. Methodology for identification of serum middle molecules.
    Buzio C, Montagna G, Calderini C, Manari A, Migone L.
    Artif Organs; 1981 Aug 03; 4 Suppl():22-7. PubMed ID: 7295090
    [Abstract] [Full Text] [Related]

  • 7. Osmotic concentration of polypeptides from hemofiltrate of uremic patients.
    Ehrlich K, Holland F, Turnham T, Klein E.
    Clin Nephrol; 1980 Jul 03; 14(1):31-5. PubMed ID: 7408253
    [Abstract] [Full Text] [Related]

  • 8. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
    Konobu K, Matsumoto T, Sawanishi K.
    Nihon Jinzo Gakkai Shi; 1988 Feb 03; 30(2):151-60. PubMed ID: 3386019
    [No Abstract] [Full Text] [Related]

  • 9. Serum middle molecules in uremia.
    Buzio C, Manari A, Calderini C, Montagna G, Migone L.
    Artif Organs; 1981 Feb 03; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract] [Full Text] [Related]

  • 10. Hemofiltration-induced serum modifications in the pattern of larger molecules.
    David S, Barani R, Buzio C, Arisi L, Quaretti P.
    Adv Exp Med Biol; 1987 Feb 03; 223():281-6. PubMed ID: 3447447
    [No Abstract] [Full Text] [Related]

  • 11. Analytical study for separation of middle molecules.
    Saito A, Kanazawa I, Chung TG, Maeda K.
    Artif Organs; 1981 Feb 03; 4 Suppl():13-6. PubMed ID: 6975092
    [Abstract] [Full Text] [Related]

  • 12. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC, Jörstad S, Wideröe TE, Svartaas TM.
    Artif Organs; 1981 Feb 03; 4 Suppl():104-9. PubMed ID: 7295075
    [Abstract] [Full Text] [Related]

  • 13. Uremic middle molecules exist and are biologically active.
    Bergström J, Fürst P, Zimmerman L.
    Clin Nephrol; 1979 May 03; 11(5):229-38. PubMed ID: 455821
    [No Abstract] [Full Text] [Related]

  • 14. Paired filtration-dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uraemic patients.
    Ghezzi PM, Zucchelli P, Ringoir S, Nigrelli S, Santoro A, Gervasio R, Sanz Moreno C, Vanholder R, Botella J.
    Adv Exp Med Biol; 1987 May 03; 223():267-75. PubMed ID: 3328955
    [No Abstract] [Full Text] [Related]

  • 15. Uremic toxins and the elusive middle molecules.
    Schoots A, Mikkers F, Cramers C, de Smet R, Ringoir S.
    Nephron; 1984 May 03; 38(1):1-8. PubMed ID: 6472528
    [No Abstract] [Full Text] [Related]

  • 16. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G, Albano V, Tancredi M, Daniele M, Pignatelli F.
    Biomater Artif Cells Artif Organs; 1987 May 03; 15(1):175-81. PubMed ID: 3449135
    [Abstract] [Full Text] [Related]

  • 17. Isolation of sialylcompounds from hemofiltrate of chronic uremic patients and identification by nuclear magnetic resonance.
    Weisshaar G, Brunner H, Friebolin H, Baumann W, Mann H, Opferkuch HJ, Sieberth HG.
    Adv Exp Med Biol; 1987 May 03; 223():219-22. PubMed ID: 3447438
    [No Abstract] [Full Text] [Related]

  • 18. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL.
    Artif Organs; 1981 May 03; 4 Suppl():8-12. PubMed ID: 7295100
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM, van Landschoot N, de Smet R.
    Clin Nephrol; 1980 Mar 03; 13(3):109-12. PubMed ID: 7379359
    [Abstract] [Full Text] [Related]

  • 20. A purification method by uncoated charcoal.
    Cerulli N, Politi L, D'Angelo AR, Scandurra R.
    Adv Exp Med Biol; 1987 Mar 03; 223():193-6. PubMed ID: 3447435
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.